Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial

• Main Authors: Ying-Ying Su (Author), Bi-Zhen Lin (Author), Hui Zhao (Author), Juan Li (Author), Zhi-Jie Lin (Author), You-Lin Qiao (Author), Li-Hui Wei (Author), Yue-Mei Hu (Author), Rong-Cheng Li (Author), Si-Jie Zhuang (Author), Guang Sun (Author), Zi-Zheng Zheng (Author), Shou-Jie Huang (Author), Ting Wu (Author), Jun Zhang (Author), Hui-Rong Pan (Author), Chang-Gui Li (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

An Escherichia. coli-produced HPV-16/18 bivalent vaccine has been proved to be well-tolerated and highly efficacious against diseases associated with vaccine HPV types. As a part of the multi-center, randomized, double-blind phase III clinical trial, this lot-to-lot consistency study aimed to assess...